These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 8387559)
1. Viral inactivation of vesicular stomatitis virus in normal human serum by cross-linked polyvinylpyrrolidone. Highsmith FA; Caple M; Walthall B; Shanbrom E; Drohan WN J Infect Dis; 1993 May; 167(5):1027-33. PubMed ID: 8387559 [TBL] [Abstract][Full Text] [Related]
2. Inactivation of lipid-enveloped and non-lipid-enveloped model viruses in normal human plasma by crosslinked starch-iodine. Highsmith FA; Xue H; Caple M; Walthall B; Drohan WN; Shanbrom E Transfusion; 1994 Apr; 34(4):322-7. PubMed ID: 8178330 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Vesicular Stomatitis Virus Inactivation by Protoporphyrin IX, Zinc-Protoporphyrin IX, and Mesoporphyrin IX. Cruz-Oliveira C; Almeida AF; Freire JM; Caruso MB; Morando MA; Ferreira VNS; Assunção-Miranda I; Gomes AMO; Castanho MARB; Da Poian AT Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348154 [TBL] [Abstract][Full Text] [Related]
4. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids. Horowitz B; Piët MP; Prince AM; Edwards CA; Lippin A; Walakovits LA Vox Sang; 1988; 54(1):14-20. PubMed ID: 2831669 [TBL] [Abstract][Full Text] [Related]
5. [Protective effect of vitamin C on protein activity in plasma during virus inactivation]. Li Y; Li MY; Jiang RJ; Jia WX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):392-6. PubMed ID: 16638223 [TBL] [Abstract][Full Text] [Related]
6. Stability and inactivation of vesicular stomatitis virus, a prototype rhabdovirus. Zimmer B; Summermatter K; Zimmer G Vet Microbiol; 2013 Feb; 162(1):78-84. PubMed ID: 22995872 [TBL] [Abstract][Full Text] [Related]
7. Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis. Mills BJ; Beebe DP; Cooper NR J Immunol; 1979 Dec; 123(6):2518-24. PubMed ID: 227957 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic inactivation of model virus in human plasma by methylene blue and its influence on plasma proteins. Wang D; Bu F; Xu J Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2000 Mar; 14(1):52-5. PubMed ID: 11503026 [TBL] [Abstract][Full Text] [Related]
9. Iodine-mediated inactivation of lipid- and nonlipid-enveloped viruses in human antithrombin III concentrate. Highsmith F; Xue H; Chen X; Benade L; Owens J; Shanbrom E; Drohan W Blood; 1995 Jul; 86(2):791-6. PubMed ID: 7606009 [TBL] [Abstract][Full Text] [Related]
10. Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Neyndorff HC; Bartel DL; Tufaro F; Levy JG Transfusion; 1990; 30(6):485-90. PubMed ID: 2165643 [TBL] [Abstract][Full Text] [Related]
11. The effect of cicloxolone sodium on the replication of vesicular stomatitis virus in BSC-1 cells. Dargan DJ; Galt CB; Subak-Sharpe JH J Gen Virol; 1992 Feb; 73 ( Pt 2)():397-406. PubMed ID: 1311361 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of vesicular stomatitis virus through inhibition of membrane fusion by chemical modification of the viral glycoprotein. Stauffer F; De Miranda J; Schechter MC; Carneiro FA; Salgado LT; Machado GF; Da Poian AT Antiviral Res; 2007 Jan; 73(1):31-9. PubMed ID: 16934341 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of interferon action. Interferon alpha inhibits vesicular stomatitis virus primary transcript accumulation in P1/eIF-2 alpha protein kinase-deficient human fibroblast cells. Zhang XT; Samuel CE J Biol Regul Homeost Agents; 1987; 1(4):157-65. PubMed ID: 2845723 [TBL] [Abstract][Full Text] [Related]
14. The nucleocapsid protein of vesicular stomatitis virus isolated from the brains of nude mice is responsible for abated viral RNA synthesis at the normal body temperature of mice. Doll SC; Johnson TC J Gen Virol; 1990 Jan; 71 ( Pt 1)():29-36. PubMed ID: 2154537 [TBL] [Abstract][Full Text] [Related]
15. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. Beebe DP; Cooper NR J Immunol; 1981 Apr; 126(4):1562-8. PubMed ID: 6259260 [TBL] [Abstract][Full Text] [Related]
16. In vitro inhibition of vesicular stomatitis virus replication by purified porcine Mx1 protein fused to HIV-1 Tat protein transduction domain (PTD). Zhang XM; He DN; Zhou B; Pang R; Liu K; Zhao J; Chen PY Antiviral Res; 2013 Aug; 99(2):149-57. PubMed ID: 23727591 [TBL] [Abstract][Full Text] [Related]
17. [Expressing of N gene encoding nucleocapsid protein of vesicular stomatitis virus and elementary application in ELISA]. Hua QY; Jin NY; Xu ZZ; Yang YQ; Dong J; Yang JY; Zhou XL Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):130-5. PubMed ID: 16108504 [TBL] [Abstract][Full Text] [Related]
18. Virus inactivation by anilinonaphthalene sulfonate compounds and comparison with other ligands. Bonafe CF; Glaser M; Voss EW; Weber G; Silva JL Biochem Biophys Res Commun; 2000 Sep; 275(3):955-61. PubMed ID: 10973827 [TBL] [Abstract][Full Text] [Related]
19. Quantification of the antiviral effect of interferon by immunoassay of vesicular stomatitis virus proteins. Wallach D J Gen Virol; 1983 Oct; 64 (Pt 10)():2221-7. PubMed ID: 6194250 [TBL] [Abstract][Full Text] [Related]